Global Core Electronic Medicinal Product Information (ePI), published by HL7 International / Biomedical Research and Regulation. This guide is not an authorized publication; it is the continuous build for version 1.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/emedicinal-product-info/ and changes regularly. See the Directory of published versions
| Page standards status: Informative |
<ClinicalUseDefinition xmlns="http://hl7.org/fhir">
<id value="cud-diflucan-renal"/>
<meta>
<profile
value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/ClinicalUseDefinition-warning-uv-epi"/>
</meta>
<language value="en"/>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p class="res-header-id"><b>Generated Narrative: ClinicalUseDefinition cud-diflucan-renal</b></p><a name="cud-diflucan-renal"> </a><a name="hccud-diflucan-renal"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px"/><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-ClinicalUseDefinition-warning-uv-epi.html">ClinicalUseDefinition Warning (ePI)</a></p></div><p><b>identifier</b>: <code>http://example.org/identifier</code>/cud-diflucan-renal</p><p><b>type</b>: Warning</p><p><b>category</b>: <span title="Codes:{http://hl7.org/fhir/uv/emedicinal-product-info/CodeSystem/epi-ig warning}">Warning</span></p><p><b>subject</b>: <a href="Bundle-bundle-epi-type3-example-diflucan.html#http-//hl7.org/fhir/uv/emedicinal-product-info/MedicinalProductDefinition/mpd-diflucan">MedicinalProductDefinition: identifier = http://ema.europa.eu/identifier#DIFLUCAN-150MG; status = Active</a></p><p><b>status</b>: <span title="Codes:{http://hl7.org/fhir/publication-status active}">Active</span></p><p><b>population</b>: <a href="Group-group-diflucan-renal.html">Renal impairment (CrCl ≤ 50 mL/min)</a></p><h3>Warnings</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Code</b></td></tr><tr><td style="display: none">*</td><td><span title="Codes:{http://snomed.info/sct 723188008}">For multiple-dose therapy, after a normal loading dose, give 50% of the recommended daily dose when CrCl ≤ 50 mL/min (no haemodialysis); give 100% of the recommended dose after each haemodialysis session. Single-dose therapy needs no adjustment. This rule applies to every multiple-dose indication.</span></td></tr></table></div>
</text>
<identifier>
<system value="http://example.org/identifier"/>
<value value="cud-diflucan-renal"/>
</identifier>
<type value="warning"/>
<category>
<coding>
<system
value="http://hl7.org/fhir/uv/emedicinal-product-info/CodeSystem/epi-ig"/>
<code value="warning"/>
<display value="Warning"/>
</coding>
</category>
<subject>🔗
<reference
value="http://hl7.org/fhir/uv/emedicinal-product-info/MedicinalProductDefinition/mpd-diflucan"/>
</subject>
<status>
<coding>
<system value="http://hl7.org/fhir/publication-status"/>
<code value="active"/>
<display value="Active"/>
</coding>
</status>
<population>🔗
<reference value="Group/group-diflucan-renal"/>
<display value="Renal impairment (CrCl ≤ 50 mL/min)"/>
</population>
<warning>
<code>
<coding>
<system value="http://snomed.info/sct"/>
<code value="723188008"/>
<display value="Renal insufficiency"/>
</coding>
<text
value="For multiple-dose therapy, after a normal loading dose, give 50% of the recommended daily dose when CrCl ≤ 50 mL/min (no haemodialysis); give 100% of the recommended dose after each haemodialysis session. Single-dose therapy needs no adjustment. This rule applies to every multiple-dose indication."/>
</code>
</warning>
</ClinicalUseDefinition>